Sexual dysfunction in cancer patients: A review

Journal of B.U.ON.

Volumn 18, Issue 4, 2013, Pages 818-823

  Cakar, B ^a   Karaca, B ^a   Uslu, R ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cancer; Chemotherapy; Radiotherapy; Sexual dysfunction; Surgery

Indexed keywords

ANASTROZOLE; ESTROGEN; GONADORELIN; LUBRICATING AGENT; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; TAMOXIFEN; TESTOSTERONE;

ANDROGEN DEPRIVATION THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; DYSPAREUNIA; GYNECOLOGIC CANCER; HUMAN; HUMIDIFIER; LIBIDO DISORDER; ORCHIECTOMY; OVARIECTOMY; POSTOPERATIVE COMPLICATION; PROSTATE CANCER; QUALITY OF LIFE; RADICAL HYSTERECTOMY; REVIEW; SEXUAL DYSFUNCTION; VAGINA ATROPHY; VAGINAL DRYNESS; VAGINAL PRURITUS;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 84893096879     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Anllo LM. Sexual life after breast cancer. J Sex Marital Ther 2000;26:241-248. (Pubitemid 30439826)
2. Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer 2004;100:97-106. (Pubitemid 37553544)
3. Dursun P, Ayhan A, Kuscu E. Nerve-sparing radical hysterectomy for cervical carcinoma. Crit Rev Oncol Hematol 2009;70:195-205.
4. Derzko C,Elliot S, Lam W. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr OnJBUON 2013; 18(4): 822 col 2007;14:20-40.
5. Cella D, Fallowfield L, Barker P et al. Quality of life of postmenopausal women in the ATAC (Arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer. Breast Cancer Res Treat 2006;100:273-284. (Pubitemid 44707921)
6. Fallowfield LJ, Bliss JM, Porter LS et al. Quality of life in the intergroup exemestane study:a randomised trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. J Clin Oncol 2006;24:910-917. (Pubitemid 46638844)
7. Burwell SR, Case LD, Kaelin C, Avis NE. Sexual problems in younger women after breast cancer surgery. J Clin Oncol 2006;24:2815-2821. (Pubitemid 46655597)
8. Okanami Y, Ito Y, Watanabe C et al. Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant antracycline and taxane. Breast Cancer 2011; 18:182-188.
9. Ganz PA, Desmond KA, Leedham B et al. Quality of life in long-term, disease free survivors of breast cancer:a follow-up study. J Natl Cancer Inst 2002;94:39-49. (Pubitemid 34082842)
10. Broeckel JA,Thors CL, Jacobsen PB, Small M, Cox CE. Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat 2002;75:241-248. (Pubitemid 35026117)
11. Santen RJ, Pinkerton JV, Conaway M et al. Treatment of urogenital atrophy with low-dose estradioh:preliminary results. Menopause 2002;9:179-187. (Pubitemid 34492326)
12. Naessen T, Berglund L, Ulmsten U. Bone loss in elderly women prevented by ultra low doses of parenteral 17beta-estradiol. Am J Obstet Gynecol 1997;177:115-119. (Pubitemid 27327321)
13. Kendall A, Dowsett M, Folkerd E, Smith I. Cautiom:Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 2006;17:584-587.
14. Melisko ME, Goldman M, Rugo HS. Amelioration of sexual adverse effects in the early breast cancer patient. J Cancer Surviv 2010;4:247-255.
15. Berrino F, Muti P, Micheli A et al. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 1996;88:291-296. (Pubitemid 26073374)
16. Yu H, Shu XO, Shi R et al. Plasma sex steroid hormones and breast cancer risk in Chinese women. Int j Cancer 2003;105:92-97. (Pubitemid 36418491)
17. Basson R, Mclnnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. Women Health Gend Based Med 2002;11:367-377.
18. Miles T, Johnson N. Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev 2010;9:CD007291.
19. Moskovic DJ, Miles BJ, Lipshultz LI, Khera M. Emerging concepts in erectile preservation following radical prostatectomy:a guide for clinicians. Int J Impot Res 2011;23:181-192.
20. Messaoudi R, Menard J, Ripert T, Parquet H, Staerman F. Erectile dysfunction and sexual health after radical prostatectomydmpact of sexual motivation. Int J Impot Res 2011;23;81-86.
21. Mulhall JP, Secin FP, Guillonneau B. Artery sparing radical prostatectomy-myth or reality? J Urol 2008;179:827-831.
22. http://www.nccn.org/professionals/physician-gls/pdf, prostate.pdf (Access date:05/01/2012).
23. Schwandt A, Garcia JA. Complications of androger deprivation therapy in prostate cancer. Curr Opin Uro 2009;19:322-336.
24. Roach M, Winter K, Michalski JM et al. Penile bult dose and impotence after three-dimensional con formal radiotherapy for prostate cancer on RTOC 9406: findings from a prospective, multi-institution al, phase I/II dose-escalation study. Int J Radiat Onco Biol Phys 2004;60:1351-1356. (Pubitemid 39601851)
25. Potosky AL, Davis WW, Hoffman RM et al. Five-yea outcomes after prostatectomy or radiotherapy for prostate cancen:the prostate cancer outcomes study. J Natl Cancer Inst 2004;96:1358-1367. (Pubitemid 39406169)
26. Padma-Nathan H, McCullough AR, Levine LA et al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res 2008;20:479-486.
27. Montorsi F, McCullough A. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy:a systematic review of clinical data. J Sex Med 2005;2:658-667. (Pubitemid 41742926)
28. Montorsi F, Brock G, Lee J et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008;54:924-931.
29. Corona G, Razzoli E, Forti G, Maggi M. The use of phosphodiesterase 5 inhibitors with concomitant medications. J Endocrinol Invest 2008;31:799-808.
30. Hatzimouratidis K, Amar E, Eardley I et al. Guidelines on male sexual dysfunctiomerectile dysfunction and premature ejaculation. Eur Urol 2010;57:804-814.
31. Weinmann W, Bohnert M, Wiedemann A, Renz M, Lehmann N, Pollak S. Post-mortem detection and identification of sildenafil (Viagra) and its metabolites by LC/MS and LC/MS/MS. Int J Legal Med 2001;114:252-258. (Pubitemid 32367158)
32. Dumestre-Toulet V, Cirimele V, Gromb S et al. Last performance with VIAGRA:post-mortem identification of sildenafil and its metabolites in biological specimens including hair sample. Forensic Sci Int 2002;126:71-76. (Pubitemid 34292531)
33. Costabile RA, Spevak M, Fishman IJ et al. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J Urol 1998;160:1325-1328. (Pubitemid 29480508)
34. Montorsi F, Guazzoni G, Strambi LF et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavemous injections of alprostadih:results of a prospective, randomised trial. J Urol 1997:158:1408-1410.
35. McCullough AR, Hellstrom WG, Wang R, Lepor H, Wagner KR, Engel JD. Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate. J Urol 2010;183:2451-2456.
36. Raina R, Pahlajani G, Agarwal A, Jones S, Zippe C. Long-term potency after early use of a vacuum erection device following radical prostatectomy. BJU Int 2010;106:1719-1722.
37. Kohler TS, Pedro R, Hendlin K et al. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int 2007; 100:858-862. (Pubitemid 47360201)
38. Engel JD. Effect on sexual function of vacuum erection device post-prostatectomy. Can J Urol 2011; 18:5721-5725.
39. Tal R, Teloken P, Mulhall JP. Erectile function rehabilitation after radical prostatectomy:practice patterns among AUA members. J Sex Med 2011;8:2370-2376.